$35.20
-0.17 (-0.48%)
Endo Pharmaceuticals (NASDAQ:ENDP)
CAPS Rating:
A specialty pharmaceutical company which is engaged in the research, development, sale and marketing of branded and generic prescription pharmaceuticals used primarily to treat and manage pain.
RSS Headlines
Fool UK